News Column

WEDC, BioForward and University Research Park Award Scholarships for BIO 2014

April 30, 2014

In partnership with the Wisconsin Economic Development Corp. (WEDC) and University Research Park, BioForward announced it is awarding 25 attendees from Wisconsin companies scholarships to participate in the BIO International Convention, a biotechnology conference.

In a release, BioForward said recipients will receive access to one-on-one partnering with internationally recognized companies in the bioscience industry and access to BIO's business partnering system, which provides access to more than 3,000 companies attending the convention.

Additionally, WEDC will host meetings for the scholarship recipient companies with international delegations and companies at the convention, which will be held June 23-26 in San Diego.

The scholarship recipients include:

-Aldevron (Madison), a service organization specializing in plasmid DNA and protein production technologies, antibody technologies, and custom services with operations in the United States and Europe and a client base spanning the entire globe

-Aztalan Engineering, Inc. (Lake Mills), an employee-owned manufacturer of precision machines parts and assemblies

-Biology Based Pharmaceuticals (Lodi), an early-stage pharmaceutical company that provides flexible cell based and immunology based assay solutions which include development, production, purification, and quality analytic services under GLP and cGMP

-BloodCenter of Wisconsin, Blood Research Institute. (Milwaukee)

-Bridge to Cures Inc. (Wauwatosa), a nonprofit corporation created to help scientific entrepreneurs in southeast Wisconsin start and grow companies that turn their research and inventions into products that target unmet medical needs.

-Centrose (Madison), a biotechnology company focused on the development and commercialization of new technologies that improve patient health; developed the first-ever synergistic drug targeting systems called the Extracellular Drug Conjugate System (EDC)

-DNAStar, Inc. (Madison), a global software company offering sequence analysis software, next-gen sequencing software, primer design software, and gene expression software for over 25 years

-EigenBio (Madison), a newly formed subsidiary of ioGenetics that has developed "breakthrough" informatics capabilities and an applied mathematical system to provide rapid and accurate immunome analysis of proteins

-Intense Engineering (Madison) designs, develops, and builds custom instruments, devices, and automated systems providing product development and engineering services for companies in the bioscience sector and high-tech start-up community

-InvivoSciences, Inc. (Madison), a developer and supplier of proprietary 3D cell/tissue culture models for highly-predictive, multi-parameter phenotypic assays in pharmacology safety and discovery screening; combination of tissue engineering technology with assay automation and sample miniaturization offers a rapid and cost effective platform for therapeutic discovery

-ioGenetics (Madison), a holding company with platform technologies in immunoinformatics and recombinant protein expression that is developing novel anti-infectives called "DBAF" (Directed Biocide antibody fusions) to treat difficult infections such as MRSA and Strep. Pneumonia

-Isomark (Madison), has developed the Canary Breath Delta Value (BDV) analyzer, which uses patented, breath monitoring technology and offers a unique non-invasive method for rapid detection of invasive infections

-Marshfield Clinic Research Foundation (Marshfield) a division of Marshfield Clinic consisting of research centers in clinical research, agricultural health and safety, epidemiology/population health, human genetics, and biomedical informatics

-Nexcyon Pharmaceuticals, Inc. (Madison), a global veterinary pharmaceutical company located in Madison and London focusing on developing medically-needed therapeutics for companion animals, obtaining regulatory approvals in the USA and EU, and setting up manufacturing process and manufacturing the approved medicines

-Next Generation Clinical Research (Madison), a Clinical Contract Research Organization (CRO) and Functional Service Provider offering development consulting, clinical trial management and medical safety services to biopharma and medical device organizations with particular expertise in Critical Care, Chronic Kidney Disease and Central Nervous System Disorders

-PeptiMed (Madison), a seed-stage biopharmaceutical company that is developing a potent siRNA molecule to down-regulate an oncogene target to treat cancer, as well as a novel nanoparticle delivery system to enable its use in animals and humans

-Primorigen Biosciences, Inc. (Madison), provides solutions for stem cell maintenance, proliferation, characterization and assay development, including Vitronectin XF, MesoTotal, a variety of human growth factors and cytokines, and high qualities antibodies and proteins for developmental markers

-Quintessence Biosciences, Inc. (Madison), a private, clinical stage biopharmaceutical company developing novel anti-cancer compounds based on patented EVADE TM Ribonuclease technology

BioForward is a member-driven state association that is the voice of Wisconsin's bioscience industry and a state chapter of the national Biotechnology Industry Organization.

As Wisconsin's lead economic development agency, with more than 600 regional and local partners, the Wisconsin Economic Development Corp. (WEDC) fosters the cooperation necessary to support sustainable business growth and job creation.

University Research Park, three miles west of the University of Wisconsin-Madison campus, is home to more than 126 companies that employ over 3,500 people.

((Comments on this story may be sent to

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Professional Services Close - Up